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DESIGN, SYNTHESIS, AND ANALYSIS OF PAIRED COILED-COIL PEPTIDIC
MOLECULAR BUILDING BLOCKS USED FOR LINEARLY CONTROLLED SELFASSEMBLY OF α-HELICAL COILED-COIL HETERODIMER PEPTIDE PAIRS
Jason DiStefano
Thesis Chair: Sean C. Butler, Ph.D.
The University of Texas at Tyler
April 2022
Molecular building blocks are fundamental to biological synthesis and processes
and have been utilized in advanced materials, drugs and drug delivery systems, and
biotechnology. Proteins have been used as molecular building blocks for the construction
of complex, well-ordered structures. Coiled-coil protein domains are essential subunits
used for the oligomerization of protein complexes, gene expression, and structural elements
of biological materials. The synthesis and assembly of proteins utilizing coiled-coil motifs
are of great scientific interest due to their potential applications in disease treatment,
biomechanical motors, nanoscale delivery systems, etc. However, assembling protein
complexes with specific morphology is still challenging because the controllability of the
protein association is complicated by multiple interactions between a diverse array of
amino acids.
Initial progress toward the design, synthesis, and characterization of paired coiledcoil peptidic molecular building blocks that can self-assemble with a high degree of
xiv

controllability are presented herein. Eight unique 32-residue peptides were synthesized,
each with one modified residue to covalently crosslink two peptides via a 1,3-dipolar
cycloaddition click reaction. Each peptide was expected to fold into α-helical coiled-coil
heterodimer peptide pairs upon association with its complementary pair. Furthermore,
each crosslinked MBB was designed to exhibit controlled self-assembly with its specific
complementary MBB. This design strategy allowed the intermolecular interactions of the
peptide to control self-assembly of multiple MBBs via association through the sidechains
of the heptadic sequences. Mass spectroscopy, size-exclusion chromatography (SEC), and
HPLC analysis show successful synthesis and purification of individual peptides.
Additional chromatographic data show successful association of dimeric coiled coils,
synthesis of crosslinked MBBs, and self-assembly of the crosslinked MBBs.

xv

CHAPTER ONE
INTRODUCTION OF COILED-COIL ORTHOGONAL PEPTIDE PAIRS
1.1 Introduction
For many centuries, the scientific community has sought to understand the
fundamental principles of life and matter. Many notable scientists pursued a greater
understanding of the individual components of a much larger system. To fully understand
the building blocks of life and matter, knowledge must be gained of the individual
components that constitute the larger structure of interest. Analyzing the building block of
a system allows for a more profound understanding of the larger structure, which leads to
a greater insight into its interaction with other structures. For example, astronomer Sir
William Herschel discovered and cataloged several hundred stars and nebulae,1,2 the
building blocks of solar systems, in the Milky Way galaxy. Through his studies, Herschel
discovered infrared radiation which has led to numerous advances in technology, as well
as furthered developments in scientific analysis.3 Neils Bohr’s classical framework of an
atom described how electrons and nuclei,4–6 the building blocks of atoms, are oriented in
the periodic elements. His contributions to atomic structures became the basis for quantum
theory and wave-particle duality.7 Friedrich Wöhler’s work in organic synthesis revealed
how atoms, the building blocks of molecules, could be manipulated to create new or larger
molecules when he first synthesized urea from ammonium cyanate.8 Wöhler opened the
door to modern organic synthesis by introducing the concept of functional groups.9
Nucleic acids, proteins, carbohydrates, and lipids, the four main macromolecules of
1

biological systems, are all functionalized building blocks for biological cells and are
studied by biochemists in order to understand their dynamic interactions. Proteins and
DNA/RNA strands are complex structures built from repeating units of smaller building
blocks of nucleotides and amino acids, respectively.
Chemical building blocks are a fundamental aspect of chemistry and biology, and
researchers have spent countless hours pursuing an understanding of each.

The

manipulation of smaller molecular or atomic units to form larger molecules and particles
has been a core component of many fields in chemistry. Polymer chemists build larger
molecules from smaller repeating building blocks called monomers, metal-organic
frameworks are building blocks for coordination polymer chemistry,10 nanochemistry
studies the self-assembly of atoms or small molecules to create nanoparticles, and
biochemistry utilizes several molecular building blocks to study chemical processes of
organisms. Discovery and understanding of these chemical building blocks are just the
beginning. Applying this knowledge to specific applications in order to mimic natural
processes or create advanced materials is the next step. For example, atomic and molecular
building blocks have been used for the manufacturing of advanced materials,11–13 the
formulation of new drugs and drug delivery systems,14–16 the advancement of technology,17
and are fundamental to biological synthesis and processes.

1.2 Molecular Building Blocks
Chemical building blocks, as related to chemistry, is a very broad term that
describes how smaller components or fragments are utilized in larger compounds or
molecules. Each field in chemistry has its own definition of what constitutes a building

2

block, and therefore it is important to narrow the focus of chemical building blocks to the
specific field of study. For organic chemistry, organic building blocks refer to the reactive
functionalized molecules or the monomer subunits that are essential components for
organic synthesis. Inorganic chemistry’s version of building blocks are called metalorganic frameworks and are used to synthesize composite inorganic clusters.18

In

biochemistry, molecular building blocks (MBBs) provide the framework for the four
fundamental macromolecular components of the cells: nucleic acids, proteins, lipids, and
carbohydrates. Furthermore, MBBs can also refer to the primary structures that comprise
these macromolecules. Interestingly, most biological structures are composed from only a
small selection of MBBs. DNA and RNA are long polymeric structures that provide
genetic information or messaging needed to construct proteins. These very large, complex
structures are synthesized from only five unique nucleosides and two saccharide building
blocks. Proteins are another very important biological component used to provide cellular
structure, function, and regulation. Many proteins are long polymers constructed mostly
from 20 natural amino acids. Carbohydrates, which are crucial to metabolic processes and
cellular energy, are derived from 32 basic saccharides. Finally, lipids are categorized into
eight classifications based on their function and most commonly provide cellular structure
and long-term energy storage.19,20 In general, cellular structure and functions are mostly
derived from only 65 basic MBBs. Therefore, MBBs provide the fundamental components
of life.
Remarkably, all cellular function or dysfunction is built around this small number
of MBBs. The cell utilizes this limited number of building blocks to carry out copious
amounts of significantly complicated functions and processes.21,22 Most proteins provide

3

cellular functionality and are considered the workhorses of the cell. It has been well
understood that the structure of the protein leads to its function. The complexity of cellular
functions and specifically the interaction of macromolecules for biochemical processes is
at the forefront of protein research. Furthermore, the rate at which the fundamental
macromolecules are synthesized in the cell is staggering. For example, translation of a
protein occurs at approximately 20 amino acids per second.23 The cell can sequence and
assembly proteins from respective amino acids with extreme efficiency and the scientific
community does not currently have the techniques to mimic protein synthesis with the same
efficacy.

Even with the best equipment available, synthesizing peptides takes

approximately one hour per amino acid depending on method, and the yield of the target
peptide decreases as the length increases.24

1.3 Protein Folding Dynamics
The versatility of protein function is not limited to the amino acid sequence but also
the ability of the biopolymer to spontaneously fold into a specifically defined structure.
Proteins naturally fold into their respective final conformation which provides the unique
functionality of that protein.25 The distinct molecular structure of each folded protein is
predominately driven by folding mechanics provided by the amino acid sequence itself,
though it is not the only factor that determines the final protein structure. Environmental
factors such as temperature, pH, ionic strength, ligand concentration, and/or voltage can
modulate protein structure, and many of these parameters are used in conjunction to
perform a specific biological or chemical function.26 Protein folding is often viewed as a
transition between two states: the native state (a folded protein in a compact, semi-rigid

4

conformation) and the denatured state (an unfolded protein in an extended, flexible
conformation).26,27 Biological activity and protein functionality are most often associated
with the native state whereas the denatured state tends to represent the nonfunctional
conformation. The stability of the native protein is determined by a delicate balance of
various enthalpic and entropic considerations. The native state is generally more stable
than the denatured state, but this stability is marginal considering that the difference in
energy states between the two conformations can be as small as a few hydrogen bonds.26
Protein solvation is another important consideration that determines overall
stability. The native and denatured protein states interact fundamentally differently with
the surrounding solvent and must be considered to understand native folding. Denatured
proteins have an undefined structured, are flexible, and have free single bond rotation along
the peptide backbone. Consequently, all residues in a denatured protein, along with their
respective hydrophobic and hydrophilic sidechains, are exposed to the solvent.26 Since
water is predominately used as the solvent in all biological systems, hydrogen bond donors
and acceptors found on the backbone and sidechains are stabilized.

However, the

hydrophobic moieties are also exposed which are unable to form hydrogen bonds with
water, in turn creating an unfavorable decrease in enthalpy. To avoid the loss of hydrogen
bonding, a structural alignment of the water molecules forms around the hydrophobic
moieties. Ice-like cages, called clathrates, develop around the hydrophobic groups of the
denatured protein. This arrangement of the clathrate water molecules maximizes hydrogen
bonding at the expense of the loss of translation and rotational freedom which is an
unfavorable decrease in entropy.26

This phenomenon is commonly known as the

hydrophobic effect and is one of the major driving forces of protein folding.

5

Figure 1.1. Torsion bond angles psi and phi allow rotation of the peptide backbone.

In order to overcome this unfavorable thermodynamic state, a structural shift in the
protein occurs. While peptide bonds are considered rigid and planar, each peptide bond
has two degrees of rotational freedom. The two single bonds on each side of the Cα carbon
can freely rotate. Rotation of the N-terminus Cα (Cα-N) single bond and the C-terminus Cα
(Cα-C) occurs within each peptide of the protein backbone, commonly referred to as the Φ
(phi) and Ψ (psi) torsion angle bonds respectively (Figure 1.1).28 Accounting for steric
restraints, Φ and Ψ torsion angle bonds rotate allowing for the protein to fold into its native
state. Upon folding, hydrophobic residues aggregate to the center of the tertiary structure
of the protein, causing them to become solvent-excluded while releasing the clathrate
waters. At the same time, the hydrophilic side-chains are arranged to the outside of the
protein structure, thus releasing a large number of water molecules that were hydrogen
bonded to the polar groups. Additionally, the backbone donors and acceptors become selfsatisfied.26 The protein naturally folds into a defined structure that generally exhibits a
hydrophobic core with a hydrophilic shell, stabilized by the surrounding water molecules.
Furthermore, the hydrophobic protein core also includes favorable London dispersion
forces, as well as, favorable enthalpic structural complementarity. The protein is further
6

stabilized by electrostatic interactions between oppositely charged residues and hydrogen
bonding-competent side-chains.26

In summary, protein folding maximizes hydrogen

bonding (a favorable increase in enthalpy), releases a large number of clathrate waters (a
favorable increase of entropy), and generates other enthalpic contributions that favor
collapse to the native state. Taken together, this causes a significant net decrease in Gibbs
free energy, ΔG, making the transition favorable.29

1.4 α-Helical Secondary Structures
Although there may be a limitless number of possible protein sequences, the small
number of amino acids used for sequencing, along with the thermodynamic effects
described beforehand, serves as the basis for the protein structural motifs and domains
commonly observed. The thermodynamics of protein folding gives rise to 3D structures
which include regular patterns observed within protein domains. The regular structural
patterns that occur within the protein are called secondary structures. Secondary structures
are small segments of the protein sequence that fold into specific, repeating
conformations.30 There are three main secondary structures that naturally occur: α-helices,
β-sheets, and loops/turns. α-Helices and β-sheets account for approximately 50% of the
secondary structure. Multiple helices and sheets are often connected via loop and/or turn
regions within the protein structure,25 giving the protein its final native tertiary structure.
Being one of the prevalent structural motifs of proteins, the properties associated with αhelices have been well defined through extensive studies. Their role in biological processes
is widespread as they provide significant functionality in most proteins. For example, α-
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helices are a key component in DNA binding,31 are almost always present in antimicrobial
peptides,32,33 and are often seen utilized in the permeation of biological membranes.33,34
The α-helical conformation was first proposed by Linus Pauling and Robert Cory
in 1950.35 This structure is best described as a spiraling assembly of amino acids with
either a right- or left-handed screw. The α-helices found in proteins are almost always
right-handed and have very specific structural parameters.36–38 Each type of helix is
characterized by the number of residues per turn. In α-helical structures, there are 3.6
residues per turn or full rotation. The distance between each full rotation and the distance
between each residue along the helix axis are known as the pitch and the rise respectively.
All α-helix structures have a pitch of 5.4 Å (i.e. 5.4 Å between each full rotation) and a rise
of 1.5 Å (i.e. 1.5 Å between each residue), as seen in Figure 1.2.39 These specific
parameters are observed because of thermodynamically favored stabilizing factors between
the carbonyl oxygen and α-amino nitrogen groups on the peptide backbone.

Figure 1.2. Structural parameters of α-helices.
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The folding of the peptide into the α-helix conformation is stabilized through
hydrogen bonds formed between the mainchain carbonyl oxygen (C=O) of each residue
and the amide hydrogen (N-H) of the fourth residue from the N-terminus.38,40 The
hydrogen bonding provides a very regular, stable conformation throughout the helix due to
each bond forming nearly parallel to the long axis of the helix. This arrangement aligns
the C=O groups to point in the same direction toward the C-terminus, along with the all
the N-H groups aligning in the opposite direction towards the N-terminus. Furthermore,
since each residue is polar and they are aligned in the same direction, the overall helical
structure forms a dipole along the helix axis with a positive N-terminus and a negative Cterminus. The hydrogen bonds between the carbonyl and amide groups also form the
intramolecular hydrophobic core with the side chains of each residue pointed outward from
the helix axis. The side chains also affect the overall stability of the helix conformation.
Certain amino acids promote stability of the conformation more than others, and therefore
are frequently observed in α-helical structures. For example, the small, uncharged side
chain of alanine fits well into the α-helical conformation. Tyrosine and asparagine have
large bulky side chains which destabilize the structure. Glycine also destabilizes the αhelix structure due to constrained rotation around the Cα. Even though glycine is a
destabilizing residue, it is often found at the ends of the helix to disrupt the continuity of
the helical structure. Proline is the least common amino acid found within the interior of
α-helices, and like glycine, is often found at the end of the sequence. This is due to its rigid
cyclic side chain and its lack of an amide hydrogen needed for intrahelical hydrogen
bonding.25,38
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The folded conformation of α-helix motifs only occurs naturally when stabilized by
complimentary scaffolds from the tertiary protein structure or additional protein domains.
The favorable intramolecular interactions of a lone α-helix are usually not enough to
overcome the thermodynamics required for folding. These helical structures require
further stabilization by complimentary interactions with residues from other protein subunits or residues from another protein domain. The helical structure is often observed to
unfold and become denatured when isolated from the complimentary scaffold interactions.
Therefore, α-helix structures are frequently accompanied with additional protein domains
to overcome the unfavorable decrease in entropy caused by folding.

For example,

myoglobin contains eight α-helical segments.41 Each helical segment is stabilized by
intramolecular hydrogen bonding discussed above and further stabilized by hydrophobic
effects and electrostatic interactions with complimentary neighboring helical structures.
Another common folding motif is the di-helical helix-turn-helix motif which
consists of two helical structures connected via a short peptide turn.42 This allows the two
helical structures to interact with each other and provides the additional enthalpy
requirements needed for each peptide sequence to fold into two separate helical structures
aligned lengthwise along their axes. This helix-turn-helix is present in all domains of life
as it is essential for DNA binding proteins. DNA binding proteins utilize one helix in the
motif to recognize and interact with the DNA major groove via hydrogen bonds and van
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Figure 1.3. Examples of α-helices used in DNA bonding and docking. (Left) Crystal
structure of a λ repressor DNA binding protein (PDB code 1LMB). (Right) Crystal
structure of JUN BZIP homodimer docking to major groove of AP-1 DNA (PDB code
2H7H).

der Waals contacts.

Another helix in the motif provides additional supplemental

interactions which adds significant contributions to the binding affinity and specificity.43
This type of motif is also commonly seen in higher-order helical bundles, such as a threehelical bundle, where the second and third helices are arranged perpendicular to each other.
This type of perpendicular arrangement allows the second helix to orthogonally dock into
the major groove of DNA (Figure 1.3).31,43

1.5 Coiled-Coil α-Helical Structures and Parameters
The focus of this study was the modular design and association of polypeptides
using another widespread protein structure found in nature. When two α-helical peptides
are long enough and exhibit specific intermolecular interactions, they begin to coil around
each other forming the characteristic coiled-coil structure. Coiled-coil helices are essential
subunits for biological processes such as oligomerization of protein complexes44 and gene
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expression45, and are commonly observed as structural elements of biological materials.46
Approximately 3-5% of all protein sequences consist of coiled-coil structural domains, and
the motif is present in up to 10% of the eukaryotic proteome.27,45
The coiled-coil structure was first described by Crick in 1953.47 Pauling and Corey
reported the first model of α-keratin in the same year.48 Approximately twenty years later
the sequence for rabbit skeletal tropomyosin was published,49 and then another decade
before the high resolution crystal structure was published showing a three-stranded coiledcoil structure within influenza virus hemagglutinin.50 Excitement for coiled-coil structures
increased a few years later when high resolution structures were published illustrating the
dimeric coiled-coil motif stabilized by what is known as a leucine zipper, such as GCN4.51
Leucine zippers are rigid coiled-coil α-helical dimers that are involved in DNA-binding
domains of transcription factors.
Because of their importance in biological functions, and their relative simplicity for
design and synthesis, coiled-coil structures have been extensively studied and
characterized.45,52–59 The key differences between coiled-coil and helix-turn-helix motifs
are the length of the peptide sequences utilized by each. Helices in helix-turn-helix motifs
are much shorter in length and are always connected via a short peptide turn. Helices from
coiled-coil structures are much longer and each helix can come from the same protein
domain or from separate polypeptide subunits. Typically, a single α-helical structure is
found to be right-handed with 3.6 residues per turn (18 residues every five turns). Since
coiled-coil structures are two individual α-helical peptides that are coiled upon each other,
the direction of the coiling of the α-helix structures will determine the overall stability of
the structure. Left-handed coiled coils effectively twist each α-helix structure tighter which
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reduces the residue rotation to 3.5 residues per turn (seven residues per two turns) for each
α-helix. The tightening of the α-helix structures in left-handed coiled bundles is driven by
hydrophobicity. As the α-helical structures distort, more contacts are formed on the
hydrophobic face. This leads to tighter packing of the hydrophobic core, and increased
stability is observed for left-handed coiled coils. In contrast, right-handed coiled coils
slightly increase the residue rotation to 3.67 residues per turn (11 residues per three turns).
This decreases hydrophobic contacts and expands the hydrophobic core leading to a less
stable conformation. Because of this, very few righted-handed coiled-coil bundles are seen
in nature.

One native right-handed coiled-coil protein is tetrabrachion from

Staphylothermus marinus which forms a right-handed coiled tetramer.
The distortion imposed on each helix of left-handed supercoils lowers the helix
rotation to 3.5 residues per turn. Thus, a seven-residue periodic pattern, referred to as a
heptad, emerges in the sequence of the peptides used within coiled coils. This heptadic
periodicity confers the structural regularity vital to the formation of coiled coils, as well as,
simplifies the design strategies and synthesis of synthetic peptides that form coiled coils.
Using the principles described by Crick’s “knob-in-hole” model,47 McLachlan’s
nomenclature of the heptad sequence,60 and the Peptide Velcro hypothesis described by
O’Shea,61 the structural elements needed for stabilizing helix dimerization have been
provided. These characterization studies opened the door to modular protein design
utilizing orthogonal interacting coiled-coil pairs. Further characterization studies by
Gradišar,62 O’Shea,51,63 and Woolfson64–68 provided additional insights into the rules
governing the folding and specificity of coiled-coil structures. Since the parameters of
coiled-coil structures have been extensively studied and are well known, a “plug-and-play”
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(a)

(b)

(c)

(d)

(e)

Figure 1.4. Example of a dimeric α-helical coiled-coil structure and respective orientation
parameters. (a) Crystal structure fragment of Tropomyosin (PDB code 1C1G). Illustrating
orientation parameters of the supercoil axis, helix-crossing angle, pitch, and pitch angle.
(b) Side view of generic α-helix with rotational distortion of 3.5 residues per turn induced
by knob-into-hole packing. (c) Side view of a generic coiled coil and its respective 20°
axis offset. (d) Side view of crystal structure of GCN4 leucine zipper (PDB code 2ZTA)
showing alignment of leucine residues (light blue) and hydrophobic residues (pink). (e)
Top view of crystal structure of GCN4 leucine zipper (PDB code 2ZTA).

type system based on coiled-coil molecular building blocks can be developed. Coiled-coil
MBBs are highly suitable building blocks for modular protein synthesis due to their
quaternary conformation predictability, their biological mimic nature, and their potential
application.
Crick’s initial model of the association of a dipeptide coiled-coil system explained
how the peptides interact spatially to form the coiling of two α-helices. The model he
proposed, and that is widely accepted, is the knob-into-hole packing model.47,66 In this
model, the sidechains of the first α-helix act as knobs that fit into the empty spaces (i.e.
holes) of the second α-helix. This knob-into hole packing is only permitted if 1) the α14

helices both distort their residue rotation from 3.6 to 3.5 residues per turn, and 2) the axis
of the two coils is offset by 20° parallel. As can be seen in Figure 1.4, the sidechains of
each peptide interlock neatly with a 20° counterclockwise rotation of the pitch axis, which
is also referred to as the pitch angle. This model explains why the association causes the
two α-helices to both reduce their rotation and coil upon each other. The amino acid
sidechains would not align with the empty space of the complementary peptide without
reducing the rotation to 3.5 residues per turn and offsetting the pitch angle. This small
distortion in the rotation of the α-helices allows for a regular, tightly packed interface. The
structural regularity also confers a seven-amino-acid periodicity which ultimately gives
these building blocks their modular capabilities.
As discussed earlier, the hydrophobic effect is one of the most dominate forces
involved in protein folding. Proteins will fold into their most stable state that maximizes
hydrophobic contact. It has been widely accepted that the folding mechanism is a twostate transition from denatured monomers to dimeric coiled coils. Studies have shown that
the folding and dimerization of dimeric coiled coils is a coupled and cooperative process
described by a two-state model.45 The peptides that compose coiled-coil systems are
usually amphipathic and this feature drives them to fold into helical structures. This allows
the peptides to form amphipathic helices that then associate with complementary helices
through their hydrophobic faces, and in certain cases are stabilized via electrostatic
interactions.
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1.6 Heptad Nomenclature and Peptide Orientation
While Crick was able to describe the spatial conformation of dimeric coiled coils,
McLachlan was the first to describe the nomenclature commonly used for the heptadic
sequences of each peptide.60 While the residues at each position of the heptad sequence
contribute to the overall stability of the peptide intramolecularly, the residues also control
intermolecular association with other peptide domains. The heptad sequence is now
commonly represented as a seven-point wheel with each point representing one of the
amino acids in the heptad sequence labeled with a letter in the string abcdefg. Each letter
is also orientated on the wheel to represent the position of the amino acid within the helical
structure that is connected via arrows.

Figure 1.5. Heptad wheel diagram. The heptad is a seven-residue repeating sequence of
an α-helix shown from the top view. Amino acids labeled with letters abcdefg connected
via arrows.

1.7 Peptide “Velcro” Hypothesis
The amino acids used at positions a, d, e, and g in each heptad sequence is
extremely important as it determines association of the peptides via hydrophobic knobinto-hole packing and electrostatic charge interaction. The oligomeric state of the protein
16

assembly and helical orientation of the peptides are also determined by the residues at these
same four positions. Therefore, these four positions are critical to the design process as
they control the specificity, stability, and final topology of the coiled-coil structure.
The amino acids at positions a and d are usually hydrophobic residues. These two
positions provide the most important contribution, energetically, as they contribute to the
hydrophobic core of the coiled coil. The hydrophobic core determines the knob-into-hole
packing pattern, which determines peptide association. Also, positions a and d strongly
influence oligomeric state of assembled proteins.45 Interestingly, the addition of the polar
uncharged amino acid asparagine (Asn) at position a is used to induce dimerization;
inhibiting the formation of higher-order oligomers. Asparagine forms buried hydrogen
bonds leading to high specificity for dimer formation and is notably seen in leucine zippers
such as GCN4.62,69
Positions e and g are commonly electrostatically charged residues which provides
the second most important contribution to the stability of the coiled-coil system by allowing
electrostatic interactions with oppositely charged residues at the same positions on the
complementary heptad. Furthermore, it has been shown that these two electrostatic
positions can be utilized in the design process of coiled-coils as they participate in the
folding process. The electrostatic interactions at positions e and g promote specificity of
the binding partner, oligomeric state, homo- or heterotypic pairing, and stability of the
peptide association.45
Coiled-coil structures can also be described by the axial orientation pf the peptide
upon association.

Parallel orientation is characterized by both helical axes aligned

lengthwise with clockwise rotations. If one the two helices is rotated 90° perpendicular to
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(a)

(b)

Figure 1.6. Parallel and antiparallel orientations of dimeric α-helices. Pairing of positions
a and d and heptad wheels in parallel orientation (a) and antiparallel orientation (b).
the axis (i.e. flipped end on end) then the orientation is considered antiparallel. Antiparallel
orientation has one clockwise and one counterclockwise helical rotation aligned lengthwise
upon their axes. The orientation is important because it changes the knob-into-hole pattern
and aligns the amino acids differently, as seen in Figure 1.6.27
While the amino acids used at positions a, d, e, and g determine the ability for
association and oligomeric state of a peptide, they also control topology. The same
residues that are used to influence the hydrophobic packing and charge patterns are also
used to regulate the preference for parallel or antiparallel orientation. Both orientations
align the hydrophobic and electrostatic residues differently, which affects the stability of
18

peptide association. Therefore, peptide orientation must be considered in the overall design
of the coiled-coil structures. In parallel orientation, the hydrophobic packing is aligned by
a-a and d-d interactions, and the salt bridges formed by g-e and e-g connections.
Antiparallel orientation aligns the hydrophobic residues in an a-d and d-a pattern, and the
electrostatic connections are formed by g-g and e-e interactions (Figure 1.6).
Positions b, c, and f are the solvent exposed residues. These peptide pairs are
frequently used within aqueous environments to mimic biological conditions. Therefore,
positions b, c, and f are commonly occupied by polar amino acids to enhance the solvation
of the coiled-coil peptides. These exposed residues also allow for unique design principles
because the sites can be engineered which specific desired properties that assist in modular
design and application of coiled-coil MBBs.

1.8 Design of Peptidic Orthogonal Interacting Pairs
Constructing complex protein assemblies from modular peptidic molecular
building blocks simply depends on the availability of the required building blocks that
satisfy the parameters for association. Like most synthetic polymers, the combination of
the building blocks typically produces a variety of products. While the target structure may
be represented in the final product produced, additional conformations and/or structures
may also be present. The same is often seen when peptide association occurs. Varying
oligomeric states with both homo- or heterotypic pairing of the assembled peptides is often
observed. The challenge lies in designing coiled-coil building blocks that bind to their
target with high specificity in order to eliminate unwanted cross-interactions, alignments,
and oligomeric states. Coiled-coil building blocks that solely bind to their designed
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partners are called orthogonal sets. Designing orthogonal sets is challenging because the
desired and off-target associations are only separated by small differences in free energy.
In 2010, Gradišar and Jerala used the principles governing stability and selectivity
described above to design eight unique peptides that form four parallel coiled-coil
orthogonal pairs.62 Gradišar used a positive and negative strategy in developing these
peptide pairs. The positive design directs the formation of the most stable target structures,
while the negative design destabilizes the competing unwanted structures. This positive
and negative design scheme maximizes the energy gap between the target and undesirable
pairs. Maximizing the energy gap of the target pairs was achieved by slightly destabilizing
the hydrophobic interactions by burying Asn residues at specific positions.62
The design of the coiled-coil peptide structures followed the principles previously
described.

With the exception of the buried Asn used to induce dimerization and

conformational specificity, heptad positions a and d were occupied with aliphatic
hydrophobic residues to form the hydrophobic core. The interactions at position a and d
were considered to be the most important contribution energetically. Peptides with the
same hydrophobic pattern were designed for orthogonal pairing. Positions e and g formed
electrostatic interactions between oppositely charged resides. The charge pattern was the
second most important contributor to the stability of the coiled coils and added additional
specificity for orthogonal pairing. Heterodimeric coiled-coil structures formed by aligning
Lys at position g on one peptide chain and Glu at position e in the complementary chain.
Studies have shown that three to four heptad repeats are the minimal number of
repeats required for a stable coiled-coil structure.62 Bromley reported a set of orthogonal
coiled-coil peptide pairs consisting of three heptads. The orthogonal sets from Bromley
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were at the lower limit for coiled-coil stability and limited the number of potential
orthogonal pairs that could be formed.65 Gradišar and coworkers focused on designing
orthogonal sets that were four heptads in length. They saw advantages to having additional
coiled-coil building blocks available with an additional heptad. An increased number of
heptads adds additional stabilization of the peptide pairs and improves the potential for
orthogonal pairs forming. Table 1.1 shows the eight peptides designed by the Gradišar
group.62
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SPED

SPED

SPED

SPED

SPED

SPED

SPED

P2

P3

P4

P5

P6

P7

P8

KIAQLKE

E IQ A L E E

KNAALKE

ENAALEE

KIAQLKQ

E IQ Q L E E

KIAQLKE

E IQ A L E E

ENQQLEQ

KNAQLKQ

E IQ A L E E

KIAQLKQ

KIQALKQ

EIAQLEQ

KNAALKE

ENAQLEQ

g a b c d e f

KIQALKE

E IA A L E E

ENQALEE

KNAALKE

ENQQLEE

KNAALKE

KNQQLKE

ENAALEE

g a b c d e f

E N A A L E Y

KNQALKY

K I A Q L K Y

E I Q A L E Y

KNAALEY

KNQALKY

K I Q A L K Y

E I A Q L E Y

g a b c d e f

ININ

ININ

NINI

NINI

IINN

IINN

INNI

INNI

Pattern

Hydrophobic

KEKE

EKEK

KEEK

EKKE

KKEE

EEKK

KKKK

EEEE

Pattern

Electrostatic

Table 1.1. Original sequences designed by Gradišar and Jerala that form orthogonal, parallel, coiled-coil peptide pairs P1|P2, P3|P4,
P5|P6, and P7|P9. The sequences are written in the one-letter amino acid code. Leucine resides that form the leucine zipper are at
position d and bolded. Hydrophobic pattern formed from residues at position a. Electrostatic pattern formed from residues at positions
e and g.

SPED

P1

SPED g a b c d e f

Sequence

1.9 Literature Review of Coiled-Coil Peptides and Possible Applications
The design of structures and functional devices that mimic nature are predominately
based on polypeptides. Structures and functionality of polypeptides are far more complex
than those based on nucleic acids due to the much larger selection of building blocks
available. Understanding polypeptide function and association is critical to designing these
structures and developing reliable design rules is necessary to link structure and function.
The coiled-coil polypeptide is one of the simplest supersecondary-structure motifs and is
frequently

observed

in

protein-protein

inter-

and

intramolecular

interactions.

Supersecondary structures are compact protein structures that contain two or more
secondary structural elements within the protein domain or subunit, such as a coiled coil.
Therefore, extensive studies have been done to characterize and understand the assembly
of coiled-coil peptides. The following is a brief review of coiled-coil peptides and their
possible applications.

1.9.1 Orthogonal Coiled-Coil Sets
Design strategies to promote orthogonal pairing of one or more α-helical peptides
has been well studied. As discussed previously, preferential pairing coiled-coil peptides
are driven by intermolecular hydrophobic and electrostatic interactions. Using these
favorable intermolecular interactions has allowed for the design of peptidic coiled-coil
bundles with varying oligomeric states and tertiary structures.
O’Shea was one of the first to develop design principles that promoted
heterodimerization while destabilizing homodimerization. Traditional leucine-alanine
sequences resulted in homodimer preferential pairing. To promote heterodimerization,
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O’Shea utilized destabilizing residue interactions in the leucine zippers. They focused on
heptad positions e and g to promote specificity of heterodimers. Glutamic acid was inserted
at these two positions for one peptide and lysine was inserted for the other peptide. Their
studies showed that formation of homodimers was destabilized and denatured at neutral
pH. When the two peptides were combined, highly helical structures were observed. This
work showed that positive/negative design principles could be utilized to promote
heterodimerization of peptide pairs.
Progress towards designing de novo peptides that form higher order oligomeric
states has also been achieved. Many supramolecular assemblies have been designed and
synthesized with varying oligomeric states, including dimers, trimers, tetramers,
pentamers, hexamers, and larger. Coiled-coil peptide bundles have been utilized for
protein fibers, enzymes, and membrane transport proteins. Schnarr and coworkers reported
the design of parallel and antiparallel coiled-coil trimers. Design of antiparallel coiled-coil
is challenging because of less well-behaved intermolecular pairing associations. Their
design used steric matching to control assembly of parallel or antiparallel associations.
Matching alanine:cyclohexylalanine at three consecutive a positions showed assembly of
parallel coils. Interestingly, moving one of the alanine:cyclohexylalanine pairings from
position a to position d showed formation of antiparallel coils. This positional shift
destabilized the parallel formation which allowed for the antiparallel formation to be more
favorable.
As discussed earlier, most superhelical bundles are formed from left-handed coiled
coils. Formation of right-handed coiled coil structures occur in nature rarely. Synthesizing
right-handed coiled coils is also challenging due to the additional parameters that must be
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considered for efficient packing of the peptide. This leads to right-handed supercoils to be
synthesized with unnatural amino acids. Sales and coworkers reported the design and
synthesis of a stable, right-handed coiled-coil tetramer with all naturally occurring amino
acids. The right-handed architecture was based on an 11-residue repeat (labeled a-k) with
hydrophobic amino acids at positions a, d, and h.
Spencer and Hochbaum reported the synthesis and crystallographic data of a coiledcoil hexamer with antiparallel association. This study showed a coiled-coil hexamer
supercoil from two unique peptides. Each peptide associated with two neighboring helices
in antiparallel conformation. Each helix was offset by one helical turn, but alternated the
shift in arrangement around the supercoil core. The C-termini of the aligned helices were
at the same height and the N-termini helices were all shifted down. This resulted in
traditional ad–da antiparallel orientation.

1.9.2 Coiled-Coil Protein Origami and Cages
Jerala and coworkers recently published a review describing modular coiled-coil
protein structures that self-assemble into complex polyhedral cages through orthogonal
dimer association. These coiled-coil protein origami (CCPO) structures form threedimensional cages that have diverse applications in biomedicine and biotechnology.
CCPO structures use protein folding dynamics along with orthogonal coiled-coil peptide
association to guide a single-chain into a polyhedron-shaped cage. The edges of the cage
self-assembly from coiled-coil dimer intramolecular interactions.

Design of CCPO

structures is a multistep process. First, the target polyhedral shape is determined. This
step is limited by the available orthogonal building blocks. Next, graph theory principle
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Eulerian path is used to develop the topology of the peptide associations and/or
conformation. Most topologies required a combination of parallel and antiparallel coiledcoil orientations. However, certain polyhedral topologies can be constructed with only
parallel (octahedron) or antiparallel (square pyramidal) coiled-coil orientation. Finally, a
single amino acid sequence is generated by the pairing of orthogonal building blocks
needed to form the edges of the shape and connected via flexible linkers. CCPO cages
have an internal cavity with a shape and volume dependent on the geometric shape chosen
and the length of the edges. Synthetic construction of a triangular prism, tetrahedron, and
square pyramid were confirmed via small angle X-ray scattering (SAXS) and single
particle TEM
Self-assembling nano-scale biomaterials has various applications for biomedicine,
material science, and biotechnology. Protein-based biomaterials with empty cavities can
be used for the production of nano-vaccines and drug delivery systems. Furthermore, the
ability to self-assembly the protein cages around a substrate adds additional feature of this
biotechnology. The outside of the protein cage can also be modified to add targeted
delivery of the payload. This allows protein engineering and the ability to build novel
structures with enhanced functionality.

1.9.3 Mimicking Protein Bioprocesses and Virus-Like Particles
New biomaterials and technologies are just one of many applications for which
coiled-coil proteins are being designed. Biomimetics and virus-like particles (VLPs) are
utilizing coiled-coil structures for mimicking dynamic cellular processes and developing
new drug technologies with target specificity.
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In 2016, Yüksel published the design of a peptide that mimicries DNA. The protein
structure utilizes coiled coils to exploit hydrophobic core packing in order to display a
specific negative charge pattern on the surface. These negatively charged surface residues
resemble the same pattern of the B-DNA double helix. This mimicking design allows the
protein Ocr to inhibit binding of the Type I restriction modification enzyme, which in turns
neutralizes the threat of hydrolytic cleavage of viral genomic material.70
Pähler reports the synthesis of four different coiled-coil oligopeptides that represent
minimal mimics of eukaryotic SNARE motifs. Pähler synthesized both parallel and
antiparallel orientations of the peptides and covalently attached them to phospholipids via
maleimide chemistry. These covalently attached coiled coils served as receptors for the
recognition of corresponding binding partners when added to solution. The study focused
on the thermodynamics and kinetics of the coiled-coil formation taking place in solution
and at the lipid bilayer.71
Virus-like particles (VLPs) are molecules that resemble viruses but do not contain
any viral genetic material. These particles can be synthesized and assembled from
individual viral structural protein subunits and they can have multiple levels of hierarchical
assembly. The VLPs can be decorated with surface modifications to direct intermolecular
interactions. One of those surface modifications can be coiled-coil proteins. These surface
coiled coils can be designed with cellular specificity and/or provide cellular membrane
permeation, which could allow the VLP to deliver drug payloads to cancer cells.72,73
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CHAPTER TWO
DESIGN AND SYNTHESIS OF COVALENTLY LINKED AZIDO- AND
PROPARGYL-FUNCTIONALIZED PEPTIDE BUILDING BLOCK PAIRS

2.1 Introduction
Presented here is the design and synthesis of eight unique peptides used to construct
a set of four orthogonal heterodimeric parallel peptide pair molecular building blocks. The
peptide pairs utilized throughout this project were designed to demonstrate controlled selfassembly of molecular building blocks through two-stranded α-helical coiled-coil
interactions. All peptides used for this study were adopted from work previously done by
Gradišar and Jerala.62 Each synthesized peptide consisted of four unique heptad sequences
following by a four-residue N-terminal extension resulting in peptides that were 32
residues in length. The characteristics of each heptad sequence and N-terminus extension
allowed for the formation and stability of the α-helical coiled-coil motif upon peptide
association with its respective peptide complement.

2.2 Design of Orthogonal Coiled-Coil Peptide Pairs
Each peptide had four heptad segments that exclusively associated with its designed
peptide complement and inhibited the association of unwanted peptide pairs. In order to
stabilize the formation of the desired associated peptide pair, heptad position a was
occupied by either Ile or Asn, and position d was occupied exclusively with hydrophobic
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residue Leu. Complementary peptide pairs were determined and selectively controlled by
the hydrophobic patterns formed at position a between the matching heptads. Only
peptides having the same repeating pattern at position a would associate with each other
while destabilizing incorrect pair formation. This selective pairing was based on stabilizing
effects of identical position a residue between the two peptides. While both pairings of
two Asn or two Ile residues at position a stabilized the association of the two peptides, the
latter pairing was seen to have a greater stabilizing effect. Furthermore, the pairing of Asn
with Ile was shown to destabilize the association which added controlled specificity.62
Similar to the hydrophobic interactions described above, electrostatic interactions
between heptad matching offered further peptide association stabilization through
oppositely charged residues at positions e and g. These positions were occupied with either
Glu or Lys. Like the hydrophobic patterns, the electrostatic patterns between the matching
heptads were designed to be complementary (oppositely charged) for increased peptide
association stability. This additional stabilization effect added another layer of control to
the formation of the correct peptide pair association while destabilizing any unfavorable
pairings.
Positions b, c, and f were occupied with Gln, Glu, or Ala. These three residues
were selected for their helix-forming propensity and to increase solubility of the peptide.
Position f on the C-terminus heptad was occupied with Tyr for peptide detection and
quantitation by absorbance spectroscopy.74
The N-terminus extension on each peptide also contributed to the stability of the
secondary and tertiary structure of the peptide. One of the main stabilizing effects of αhelical structures is the intramolecular hydrogen bonds formed within the backbone. The
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α-helix structure is maintained by hydrogen bonds formed between each C=O(i) and
N−H(i+4) four residues ahead, i–(i+4). N-terminus residues have four amide hydrogens
that lack the additional i–(i+4) hydrogen bonds, decreasing stability of the helix towards
the N-terminus end of the peptide. N-terminus stabilizing residues of α-helices have been
studied and are frequently used as capping residues.75 These unique capping residues have
special dihedral angles, stabilize helical dipole, or form additional hydrogen bonds with
the peptide backbone.62 All eight peptides in this project were capped with the tetrapeptide
SPED.
These stabilizing design features: the pairing of two Ile or Asn at position a, the
Leu zipper at position d, the electrostatic stabilization of oppositely charged residues at
positions e and g, the N-terminus extension, were all shown to be the most favorable
combination for formation of parallel α-helical coiled-coil polypeptides and were vital to
the controllability of multiple MBB associations.

2.3 Design of Heterodimer Peptidic Molecular Building Blocks
While the molecular design of the peptide sequences from Gradišar and Jerala
showed controlled association of two peptides, this project focused on the controlled selfassembly of multiple heterodimer peptide pair molecular building blocks that linearly
associate with an α-helical coiled-coil motif. This was achieved by first covalently
crosslinking two peptides, then associating these crosslinked peptidic building blocks with
their respective peptide pair. All eight peptides synthesized in this project were designed
to be paired via a covalent linkage, while maintaining their specificity to associate with
only one complementary peptide in an α-helical coiled-coil motif. The parameters
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governing the selectivity and stability of the peptide association were controlled by the
heptad sequence design previously discussed. The third heptad was further modified with
one unnatural amino acid residue at position f which allowed crosslinking between specific
peptide partners. Position f of this heptad is opposite of the hydrophobic core that is formed
during peptide association. This allows two peptides to be covalently paired while leaving
the heptad sequence of each side of the newly formed pair open for association with
additional peptides. Since each peptide also has been designed for orthogonal association,
the crosslinked peptide pair also retains its designed selectivity and specificity on each side.
The modification of position f with azido-L-ornithine or homopropargyl-glycine added the
ability to covalently link two of the peptides together via a 1,3-dipolar cycloaddition click
reaction. These covalently linked peptide pairs initially represented the four distinct
molecular building blocks designed for this project. As shown in Table 2.1, the individual
peptide sequences synthesized for this project were labeled as P1 through P8, respectively.
Based on circular dichroism studies by Gradišar 62 and HPLC analysis (Figure D.1),
it was determined that P1 may self-dimerize. Based on this evidence of self-dimerization,
P1 was removed from further study as orthogonal heterodimer pairing would not be
obtainable. The removal of P1 from the study resulted in the removal of its respective
associating peptide partner P2 also. The three remaining MBBs then became the focus of
the study.
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2.3.1 Molecular Modeling of MBBs
Using ChimeraX modeling software, visual representations of each MBB were
generated. As discussed earlier, the peptides of the MBBs do not have a defined structure
(i.e. random coil) until association occurs. However, the MBB molecular models that are
presented here were generated with standard α-helical parameters. The models presented
are visual representations of the MBBs in their native states as folded α-helical structures.
All Φ and Ψ torsion angles were constructed with −57° and −47° respectively for each
peptide. While these parameters may not represent the true torsion angles or account for
any axial bends and offsets, they do provide a basic 3D structure of the MBBs with αhelical motifs. Figure 2.1 shows the visual 3D illustrations of MBB P3–P5 and P4–P6.
Other MBBs using different peptides would be similar.

Figure 2.1. Visual 3D representations of MBB P3–P5 (left) and P4–P6 (right).
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SPED

SPED

SPED

SPED

SPED

SPED

SPED

P2

P3

P4

P5

P6

P7

P8

KIAQLKE

E IQ A L E E

KNAALKE

ENAALEE

KIAQLKQ

E IQ Q L E E

KIAQLKE

E IQ A L E E

ENQQLEQ

KNAQLKQ

EIQ A L E E

KIAQLKQ

KIQALKQ

EIAQLEQ

KNAALKE

ENAQLEQ

g a b c d e f

KIQALKX

EIA A L E X

ENQALEZ

KNAALKZ

ENQQLEX

KNAALKX

KNQQLKZ

ENAALEZ

g a b c d e f

EN AA L E Y

KNQALKY

K I A Q L K Y

E I Q A L E Y

KNAALEY

KNQALKY

K I Q A L K Y

E I A Q L E Y

g a b c d e f

ININ

ININ

NINI

NINI

IINN

IINN

INNI

INNI

Pattern

Hydrophobic

KEKE

EKEK

KEEK

EKKE

KKEE

EEKK

KKKK

EEEE

Pattern

Electrostatic

Table 2.1. Sequences of designed peptides used for molecular building blocks. Peptide pair associations (P1|P2, P3|P4, P5|P6, and
P7|P9) have the same hydrophobic patterns and oppositely charged electrostatic patterns. Modified amino acids Z and X at position f
in the third heptad (italicized and underlined) are azido-L-ornithine and homopropargyl-glycine respectively. Covalently crosslinked
peptides are comprised of one peptide with an azido modified amino acid and one peptide with an alkyne modified amino acid.

SPED

P1

SPED g a b c d e f

Sequence

2.4 Overview of 1,3-Dipolar Cycloaddition Click Reaction
The 1,3-dipolar cycloaddition reaction is a chemical reaction that forms a 1,2,3triazole five-membered ring from a 1,3 dipole and a dipolarophile. While the 1,3-dipolar
cycloaddition reaction was first described by Michael in 1893, Rolf Huisgen has become
known for describing the mechanism and synthetic applications of these types of reactions
in the 1960s. Huisgen’s work predominately focused on the addition of an organic azide
and an alkyne, and therefore the 1,3 dipolar cycloaddition is sometimes referred to as the
Huisgen cycloaddition.76–78
The dipolar azide-alkyne cycloaddition (AAC) reaction offers immense versatility
and broad application for covalently linking small molecules via azide and alkyne
functionality. However, Huisgen’s method has some limitations, as it requires longer
reaction times and higher temperatures. Products from this method are also difficulty to
purify through column chromatography and form non-regioselective triazoles (1,4- and
1,5-disubsituted triazoles).
Sharpless and Meldal both independently discovered that 1,4-disubstituted
triazoles, with good-to-quantitative results could be produced with a Cu(I)-catalyst. This
new copper catalyzed azide-alkyne reaction (CuAAC) offered notable improvements on
the original uncatalyzed AAC (Scheme 2.1).

The CuAAC method produced

regioselectivity, shorter reaction times, and could be done at room temperature.78 The term
“click chemistry” was first introduced by Sharpless during the 217th American Chemical
Society annual meeting in 1999. According to Sharpless, a click reaction must meet the
following criteria: the reaction must be modular, easy to carry out, have broad substrate
scope, mild reaction conditions, have readily available starting materials or reagents and
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Scheme 2.1. Generic AAC reaction (top) and CuAAC reaction (bottom).

the use of either solvent-free conditions or an environmentally benign solvent that can be
removed easily, generates only harmless by-products that can be free from the sole product
without any difficulty, gives products reasonably in high-to-excellent yields with ease of
isolation, and be regioselective and stereospecific.79 Based on these criteria, Sharpless
classified click reactions into four main categories: (a) nucleophilic substitutions at a
saturated carbon atom including ring-opening chemistry of epoxides, aziridines, etc.; (b)
cycloaddition reactions such as Huisgen’s 1,3-dipolar [3πs + 2πs] cycloaddition and DielsAlder [4πs + 2πs] cycloaddition; (c) non-aldol type transformations of carbonyl and related
compounds; (d) addition to carbon-carbon multiple bonds as seen in aziridination,
epoxidation, dihydroxylation, aminohydroxylation, thiol-ene click, thiol-yne click, 1,4conjugate additions, etc.79 Sharpless’s CuAAC reaction fulfills all the above criteria and
could be considered an ideal click reaction. The CuAAC reaction has gained significant
interest for its broad application, especially in synthetic biochemistry fields, as to allows
covalent coupling of complex molecules, peptides, nucleotides, or proteins that can be
carried out in biological conditions.
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The mechanism for the CuAAC reaction is shown in Scheme 2.2.76,78,80 The active
Cu(I) catalyst can be provided directly from Cu(I) salts or from Cu(II) salts that have been
reduced with sodium ascorbate. Mechanistic studies have shown that copper acetylide is
first formed with the alkyne. A second π-bound copper then coordinates to the alkyne.
The second copper acts as a stabilizing donor ligand that allows ring contraction of a
triazolyl-copper intermediate. Protonolysis then occurs producing the triazole product.

Scheme 2.2. Mechanism of CuAAC reactions.
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2.5 Copper Coordinating Triazole Tertiary Amine Ligands
The CuAAC click reaction is powerful coupling reaction that serves a vital role in
chemistry and biochemistry. Copper(I) coordination chemistry is also found in several
essential metabolic enzymatic activities that utilize electrolytic redox processes, such as
absorbtion and reduction of O2 in myoglobin. However, Cu(I) is thermodynamically
unstable and readily oxidizes to Cu(II). To prevent oxidation, strict reaction conditions are
necessary when utilizing copper(I)-mediated processes. Generally, anhydrous solvents and
inert atmospheres are required, but these conditions do not mimic biological systems.
Ongoing research into developing reliable CuAAC that are useful to both synthetic
chemistry and complex biological systems has led to the addition of polytriazolylamines
for peptide ligation.76,81,82 Polytriazolylamines help overcome many of the limitations of
CuAAC by enhancing the efficiency and yield of the reactions in aqueous environments.

Figure 2.2. Tetradentate coordination of copper(I) and TBTA ligand. Compound name:
bis(µ2-(tris(1-Benzyl-1,2,3-triazol-4-ylmethyl)amine))-di-copper(I).
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In 2004, Folkin reported a series of polytriazoles that could function as ligands in
CuAAC.81 That study observed a dramatic increase in the redox potential of Cu(I)/Cu(II)
when CuAAC was carried out in the presence of a polytriazole. Out of all the compounds
studied by Folkin, tris((1-benzyl-4-triazolyl)methyl)amine (TBTA) was observed to
perform the best. It was proposed that TBTA stabilizes the Cu(I) oxidation state by forming
a tetradentate chelate around the Cu(I) atom (Figure 2.2). The TBTA blocks all possible
coordination sites from potential oxidation, even in aqueous solvents. While TBTA
stabilizes the Cu catalyst and enhances efficiency in aqueous based CuAAC, it does suffer
from low water solubility and must first be dissolved in an organic solvent such as DMF.
Several studies of similarly structured tetradentate ligands of TBTA have followed.
Inspired by TBTA, researchers have developed a class of ligands polytriazolylamines with
better biocompatibility (Figure 2.3).76
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Figure 2.3. Copper-coordinating ligands used to accelerate CuAAC reactions.
(a) TBTA and analogues; (b)
tris(heteroarylmethyl)amine ligands; (c) 2,2’ -bipyridine and 1,10-phenanthroline derivatives; (d) tris(1-benzyl-1H-1,2,3-triazol-4yl)methanol; (e) L-histidine; (f) P-donor ligands.76

One of the goals of the work presented here was focused on optimizing the CuAAC
of the previously described azido/alkyne peptide pairs. However, the work did not strictly
limit reaction conditions to mimic biological conditions. Because this initial work focused
on developing methods and characterization for proof-of-concept of controlled assembly
of the molecular building blocks, CuAAC reactions were performed under various
conditions with accelerating ligands in nonbiological solvents such as DMF.

2.6 CuAAC Click Reaction of Peptide Pairs
Covalently crosslinking two peptides via CuAAC reactions was approached from
two perspectives. The first approach joins the two peptides without the help of any solid
phase support while the other approach utilizes the resin on which the individual peptides
are synthesized. Both approaches have advantages and disadvantages.
The first approach to bonding two peptides together through CuAAC reactions was
attempted off-resin. Both peptides were cleaved from their respective resins before being
used in the CuAAC. This method allows the peptides and reagents to be unhindered and
eliminates any steric hinderance associated with immobilizing the peptides to the resin.
This should increase yield of the CuAAC reaction because the molecules have a higher
probability of aligning their p-orbitals in the conformation needed for the 1,3-dipolar
cycloaddition reaction. However, this approach will also contaminate the product with any
unreacted peptide, which would include both of the individual peptides, and the CuAAC
reagents. This makes purification of the clicked product more difficult and any unreacted
peptide associated with the clicked product will still undergo paired association with its
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respective peptide partner. Furthermore, the copper used in the CuAAC is cytotoxic must
be removed if these MBBs are to be used within biological conditions.
The other method utilizes one peptide that remains on the resin support and one
peptide that has been cleaved from its respective resin. This method allows for easy
separation of the CuAAC reagents and the unreacted peptide that is not on the resin support.
The disadvantage to the method may lower yields caused by steric hinderance. Each
peptide is an unfolded, random coil until becomes associated with its respective peptide
pair. Therefore, for the CuAAC reaction to take place, the off-resin peptide must navigate
in-between the bound, on-resin peptides and align into the correct bonding position. The
steric hinderance is further complicated by the sequence position of the azide/alkyne
modified amino acid on the resin bound peptide. This modified residue is at position eight,
which is very close to the resin, leaving the remaining 28 residues to form a random coil
barrier. The addition of an accelerating ligand complex also adds another bulky mechanic
to this method.
Despite the steric hinderance disadvantages, the on-resin CuAAC approach became
the focus of this project because of the simplicity of purification. This on-resin method
allowed for all reagents and any unreacted off-resin peptide to be removed, leaving behind
the clicked MBB and any on-resin peptide that did not undergo the CuAAC reaction.

2.7 Controlled Self-Assembly of MBBs
The final design process of this project was the controlled self-assembly of the
MBBs. The MBBs were designed to have controlled assembly through a stepwise addition
method. Since each peptide only associates with one of the eight unique peptides, each
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side of the MBB will only associate with one respective peptide or one side of another
MBB that has the respective peptide for association. This association specificity is what
contributes to the modularly controlled self-assembly of multiple MBBs.
One side of the starting MBB must first be capped with an individual peptide to
ensure that side of the MBB no longer has functionality for additional assembly of MBBs.
Scheme 2.3 shows the controlled self-assembly of the MBBs for this project. Based on the
design parameters, MBBs could be added to the uncapped side until it is capped with a lone
peptide pairing partner or until peptide precipitation occurs.

(a)

(b)

Scheme 2.3. Controlled self-assembly of peptidic MBBs. a) Capping of P3-P5 with P4 to
prevent further association with the P3 side of the MBB. b) Assembly of P4-P6 with P3P5 showing the controlled association of the P5|P6 interaction.
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CHAPTER THREE
EXPERIMENTAL DETAILS AND CHARACTERIZATION OF PEPTIDES AND
PEPTIDE PAIRS

3.1 Introduction
Studying protein interactions relies on acquisition of the protein of interest. This
can be done either through natural extraction from cells or from synthetic methods. Each
has advantages and disadvantages.

Cellular extraction of specific proteins provide

naturally created proteins by the cell but only in very small amounts. Synthetic proteins
can be produced in larger amounts but consume considerable amounts of solvents and are
limited to small proteins or peptides. Both processes are very time consuming due to their
respective isolation or synthetic methods, purification, and characterization. Production of
synthetic peptides has predominately been done via gene expression or solid-phase peptide
synthesis. Advances in solid-phase peptide synthesis (SPPS) have allowed chemists to
synthesize complex peptidic building blocks needed to create biomacromolecules.
Furthermore, solid-phase synthesis excels in producing proteins that are difficult for gene
expression, such as modified proteins, mirror-image proteins, and proteins with unnatural
amino acids. Solid-phase peptide synthesis has become a routine practice to produce
peptides because it can be automated, completed with low-cost amino acid building blocks,
and without complicated setups.

However, there are certain limitations for SPPS.

Synthesizing peptides through solid-phase techniques is typically limited to 50 residues.
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Yields of large peptides are statistically truncated due to the stepwise linear synthesis
process as each coupling cannot obtain 100% yield. Plus, incomplete coupling and
aggregation occurs more readily as the length of peptides extends. These limitations have
been overcome with the addition of microwave assisted synthesis, but this also adds
additional instrumentation expenses and a large excess of amino acid building blocks and
reagents. A comprehensive review of SPPS was published by Jaradat in 2017.83

Scheme 3.1. Solid-phase peptide synthesis (SPPS) of amino acid sequences.

3.2 Synthesis of Individual Peptides
Individual peptide sequences were synthesized using standard microwave-assisted
solid phase peptide synthesis (MW-SPPS) on a Biotage® Initiator+ Alstra™ peptide
synthesizer. Scheme 3.1 shows the general method used for the synthesis of the peptides.
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Each amino acid coupling was conducted using standard Fmoc-piperidine deprotection
chemistry and diisopropylcarbodiimide (DIC) and Oxyma amide coupling conditions.
Each peptide was synthesized on a 0.2 mmol scale from amino acid solutions (0.1 M in
DMF, 4 equiv.) Each amino acid was coupled in sequence starting with preloaded Cterminal tyrosine bound Wang resin (0.56 mmol/g).

The resin was swelled with

dimethylformamide (DMF) at 70 °C and 130 W for 20 min with an oscillating mixer. Fmoc
deprotection of amines was performed with piperidine (20 vol% in DMF, 90 equiv.) in two
stages (rt for 3 min followed by rt for 10 min). Both stages utilized oscillating interval
mixing at 10/15 seconds on/off. Coupling of all amino acids were performed using DIC
(2 M in DMF, 4 equiv.) and oxyma (4.5 M in NMP, 4 equiv.) activation in one stage (75
°C and 130 W for 5 min with oscillation). The mechanism for the DIC/oxyma peptide
coupling is shown in Scheme 3.2. The N-termini of all peptides were deprotected with the
same Fmoc-deprotection method. Following peptide synthesis, all resins were washed with
dichloromethane (DCM, 3 x 10 mL). Resins were dried under vacuum for ~2 h then stored
at −20 °C.
As needed, peptides were cleaved from the resin for analysis and/or covalent
bonding with the complementary azido/alkyne peptide pair. Peptides were cleaved with
agitation for 2 h using a cleavage cocktail of trifluoroacetic acid (TFA), triisopropylsilane
(TIS), and H2O (95:2.5:2.5 vol%). The peptide solution was separated from resin via
filtration. The resin was washed and filtered with DCM (3 x 5 mL) to maximize yield. All
washings were combined with peptide solution. The cleavage cocktail and DCM was
evaporated and reduced to ~25% volume via air stream. Diethyl ether was added to
precipitate the peptide product. The peptides were centrifuged with a Beckman Coulter
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25R Allegro Centrifuge (8000 rcf for 30 min at 20 °C). The supernatant was decanted and
peptides were washed with fresh diethyl ether. The peptides were centrifuged, decanted,
and washed for a total of four cycles. The peptides were dried under vacuum for ~2 h then
stored at −20 °C.

Scheme 3.2. Mechanism for DIC/oxyma peptide coupling

3.3 Characterization of Individual Peptides
3.3.1 High-Performance Liquid Chromatography
Analytical reverse phase high-performance liquid chromatography (RP-HPLC)
was used to determine purity of synthesized peptides. Individual peptides were analyzed
via HPLC using an Agilent 1200 Series HPLC. Peptide solutions (1-5 mg/mL, 0.1%
ammonium bicarbonate) were manually injected (20 µL) and separated with an Agilent
ZORBAX Eclipse Plus C18 column (4.6 x 100 mm, 3.5 µm). Eluted components were
monitored by UV absorbance at 210 and 280 nm.
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During method development, various elution parameters were evaluated. Millipore
H2O/TFA (99.9:0.1 vol%) and acetonitrile/Millipore H2O/TFA (97.9:2:0.1 vol%) were
initially used as mobile phase A and B, respectively. The concentration of B was increased
linearly from 0 to 90% over 90 minutes with a total flow rate of 1 mL/min. To reduce
solvent usage and run time of the instrument, [B] started at 20% and was increased linearly
by 1% per minute until it reached 40%. The linear gradient was then increased to 5% per
minute until [B] reached 90%. This stepwise linear gradient was used for peptide analysis
for many samples at the beginning of the project. It was observed, during method
development, that the target peptide would only elute from the column at a very specific
concentration of B.

Furthermore, the initial method development was designed for

purification of the peptides via a semi-preparative column (see Appendix B).
Later in the project, it was determined that the crude synthesized peptides were of
sufficient purity to begin developing methods for the CuAAC clicked peptide pairs. In
order to maximize resolution, the HPLC analysis method was reverted back to increasing
[B] by 1% per minute from 0 to 90% over 90 minutes. Additionally, the elution solvents
were simplified to Millipore H2O/TFA (99.9:0.1 vol%) and acetonitrile/TFA (99.9:0.1
vol%) for mobile phase A and B respectively. Figures D.1–D.10 illustrate representative
HPLC chromatograms of individual peptides.

3.3.2 Size-Exclusion Chromatography
Size-exclusion chromatography was performed on a Bio-Rad NGC™
Chromatography FPLC system. Using an HR10/30 Superdex 70 column, peptide solutions
(1-5 mg/mL in 0.1% ammonium bicarbonate) were filtered through a 0.2 µm filter,
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manually injected (300 µL), and eluted with PBS elution buffer (pH 7.4). The elution of
the peptides were monitored by UV absorbance at 280 nm.

3.3.3 Mass Spectrometry
Individual peptides were characterized by mass spectroscopy.

Since mass

spectroscopy was not available to be performed on-site, samples were sent to participating
collaborators for analysis. Some samples were characterized by time-of-flight (TOF)
methods while others were characterized by matrix-assisted laser desorption/ionization
(MALDI). Figures F.1–F.8 illustrate representative MS spectra of individual peptides.

3.4 Synthesis of Peptide Pairs via CuAAC Reactions
3.4.1 CuAAC Reaction of P3 and P5 with CuSO4
Individual solutions of P3 and P5 were prepared in 1.5-mL centrifuge vials. The
concentration of each solution was determined spectroscopically using a Thermo
Scientific® NanoDrop 2000 spectrophotometer. and peptides P3 (2.23 µmol, 1 equiv.) and
P5 (2.23 µmol, 1 equiv.) were add to a 1.5-mL centrifuge vial. Sodium ascorbate (2.23
µmol, 1 equiv.) and CuSO4 (2.23 µmol, 1 equiv.) was added to the peptide solutions. The
reaction mixture was placed on a wrist shaker and agitated for 96 hours.

3.4.2 CuAAC Reaction of P3 and P5 with CuI
A vial was fitted with a rubber septum and purged with argon gas. A catalyst
solution of sodium ascorbate (0.01 mmol, 0.5 equiv.), copper(I) iodide (0.04 mmol, 2
equiv.), water (0.6 mL), DMF (2.4 mL), and diisopropylethylamine (DIEA, one drop) was
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prepared. Peptides P3 on resin (0.02 mmol based on effective loading, 1 equiv.) and P5
(0.04 mmol, 2 equiv.) were added to a separate vial. The vial was fitted with a rubber
septum and purged with argon gas. DMF (1 mL) was injected to dissolve the peptides,
followed by injection of the catalyst solution (3 mL). The vial was purged with argon gas
again and agitated with a wrist shaker for 24 hours. The resin peptide product was washed
with DCM (3 x 3 mL), acetonitrile (3 x 3 mL), DMF (3 x 3 mL), methanol (3 x 3 mL),
water (3 x 3 mL), DCM (3 x 3 mL), and was cleaved from resin using same method
described in previously, resulting in a white solid.
The catalyst solution was a cloudy, brownish-orange color and the CuI did not
dissolve. The reaction mixture became very cloudy upon injection of the catalyst solution
to the resin. The resin color was observed to change from orange (before CuAAC) to dull
green (after CuAAC). A solid white precipitate was observed to be present with the resin.
Additionally, none of the washing solvents were able to dissolve the white precipitate. The
white precipitate was not present after peptide cleavage, suggesting that the cleavage
cocktail dissolved the precipitate. Also, the dull green color of the resin was removed
leaving behind opaque resin beads. The product was analyzed via SEC and HPLC. The
elution volume of the clicked product shifted to 13.05 mL. This is 0.16 mL less eluting
volume when compared to the elution volume of P3 at 13.21 mL. The shift to less eluting
volume suggests that P3-P5 was produced.

3.4.3 CuAAC Reaction of P3 and P5 with TPMA
Peptide P3 on resin (0.01 mmol based on effective loading, 1 equiv.), P5 (0.01
mmol, 1 equiv.), tris(pridylmethyl)amine (TPMA, 5 µmol, 0.5 equiv.), and DMF (3.4 mL)
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was added to a vial. In separate vials, concentrated solutions of CuSO4 and sodium
ascorbate was freshly prepared. These two solutions were prepared at high concentrations
and were adjusted to their respective molar equivalents when added to the reaction vessel.
Copper sulfate (2.5 µmol, 0.25 equiv.) was added to the peptide vial. The peptide vial was
fitted with a rubber septum and purged with argon gas. Sodium ascorbate (5 µmol, 0.5
equiv.) was injected into the peptide vial. The peptide vial was purged with argon a second
time and then placed on orbital shaker for 24 h. The resin peptide product was washed
with DCM (3 x 3 mL), DMF (3 x 3 mL), water (3 x 3 mL), and DCM (3 x 3 mL). Product
was cleaved from resin using same method described in previously, resulting in a white
solid product.
The reaction mixture slowly turned a red color during the 24 hours of shaking. The
product was analyzed via SEC and HPLC. The elution volume of the clicked product had
a minimal shift to 13.18 mL. The eluting volume of this product only changed by 0.03 mL
when compared to the elution volume of P3 at 13.21 mL. This minimal shift in elution
volume suggests that the reaction did not proceed as planned and TPMA is not an effective
accelerating ligand for CuAAC reactions.

3.4.4 CuAAC Reaction of P3 and P5 with TBTA
Peptide P3 on resin (0.01 mmol based on effective loading, 1 equiv.), P5 (0.01
mmol, 1 equiv.), TPMA (5 µmol, 0.5 equiv.), and DMF (2 mL) was added to a 15-mL
concial centrifuge tube. In separate vials, concentrated solutions of CuSO4 and sodium
ascorbate was freshly prepared. These two solutions were prepared at high concentrations
and were adjusted to their respective molar equivalents when added to the reaction vessel.
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Copper sulfate (0.025 mmol, 2.5 equiv.) and sodium ascorbate (0.05 mmol, 5 equiv.) was
added to the peptide vial. The peptide vial was fitted with a rubber septum, purged with
argon gas, and then placed on orbital shaker for 24 h. The resin peptide product was
washed with DCM (3 x 3 mL), DMF (3 x 3 mL), water (3 x 3 mL), and DCM (3 x 3 mL).
The product was cleaved from resin using same method described in previously, resulting
in a white solid product.
There was a noticeable difference in the reaction mixture when compared to
previous methods. First, the resin turned to a dull green color similar to the CuI method,
but the reaction mixture remained clear for the 24 hours of shaking. The resin also seemed
to aggregate and stick the centrifuge tube. During the washing cycles, the resin looked
larger in size, aggregated in the solvents, and turned an off-white color. SEC analysis
showed an elution volume of the clicked product at 13.02 mL. The eluting volume of this
product shift by 0.19 mL when compared to the elution volume of P3 at 13.21 mL. This
method caused the greatest shift in the elution volume which suggests the TBTA was the
most effective CuAAC accelerating ligand tested during this project. HPLC analysis
showed unreacted P3 was present in the product, which was expected. The HPLC
chromatogram also showed eluted peaks at the same time as P5, which should not be
present in the product. Based on the available data collected at the time of this writing, it
is proposed that P5 and P3-P5 have the same elution profile.

51

3.5 Characterization of Covalently-Linked Peptide Pairs
3.5.1 High-Performance Liquid Chromatography
Individual peptides were analyzed via reverse phase high-performance liquid
chromatography (RP-HPLC) using an Agilent 1200 Series HPLC. Peptide solutions (1-5
mg/mL in 0.1% ammonium bicarbonate) were manually injected (20 µL) and separated
with an Agilent ZORBAX Eclipse Plus C18 column (4.6 x 100 mm, 3.5 µm). Millipore
H2O/TFA (99.9:0.1 vol%) and acetonitrile/TFA (99.9:0.1 vol%) were used as mobile phase
A and B, respectively. Eluted components were monitored by UV absorbance at 210 and
280 nm. The concentration of B was increased linearly from 0 to 90% over 90 minutes
with a total flow rate of 1 mL/min. Figures D.12–D.16 illustrate representative HPLC
chromatograms of products isolated from CuAAC reactions between P3 and P5.

3.5.2 Size-Exclusion Chromatography
Size-exclusion chromatography (SEC) was performed on a Bio-Rad NGC™
Chromatography FPLC system. Using an HR10/30 Superdex 70 column, peptide solutions
(5 mg/mL in 0.1% ammonium bicarbonate) were filtered through a 0.2 µm filter, manually
injected (300 µL), and eluted with PBS elution buffer (pH 7.4). The elution of the peptides
were monitored by UV absorbance at 280 nm.
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CHAPTER FOUR
CONTROLLED ASSEMBLY OF HETERODIMER COILED-COIL PEPTIDIC
MOLECULAR BUILDING BLOCKS

4.1 Introduction
The main focus of this project was to show proof-of-concept in controlled assembly
of multiple MBBs. As discussed previously, the peptides were designed to have only one
associating partner, which allows for the controlled assembly of the MBBs. At the time of
this writing, clicked peptide product P3-P5 was the only MBB synthesized, and therefore
is the focus of this chapter. The following is an in-depth SEC analysis of the association
of the individual peptides and the association of P3-P5 with respective peptide partners.
The data presented supports the successful synthesis of P3-P5 along with the controlled
assembly of P4 and P6 to P3-P5.
The SEC data presented here shows unique associations of P3, P4, P5, and P6.
Size-exclusion chromatography is dependent on the size (physical and/or weight) and the
shape of the analyzed peptides. Some of the data presented shows expected shifts in the
elution volume while other data shows unexpected shifts. However, all the data presented
supports unique changes in the molecular structure as assembly of MBBs occurs. Along
with the support for the successful synthesis of P3-P5, the data also suggests that the
associations of P3-P5|P6 and P4|P3-P5|P6 were also formed.
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4.2 Characterization of Peptidic Intermolecular Association
The first step of the project was to confirm that the orthogonal association of
peptide partners P3|P4 and P5|P6 occur as designed.

Figure 4.1 shows the SEC

characterization of individual peptides P3 (red) and P4 (blue) before they were associated.
The same chromatogram also compares the dimerization of P3|P4 (black) at a 1:1 molar
ratio. The data shows a distinct shift in the elution volume of the dimer when compared to
the individual peptide components, which correlates to the successful association of the
two individual peptides. The peak shape of P3|P4 also suggests complete homogenous
association of the two peptides, signifying that partial association does not occur. Figure
4.2 shows the same results for the individual peptides P5 (blue) and P6 (red) dimerizing
into P5|P6 (black). However, P6 does elute slightly faster than P5, suggesting that the
shape of the random coil of this peptide is slightly different as it passes through the SEC
column.

Figure 4.1. SEC analysis of P3 (red), P4 (blue), and associated pairing of P3|P4 (black).
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Figure 4.2. SEC analysis of P5 (red), P6 (blue), and associated pairing of P5|P6 (black)

4.3 Characterization of MBB P3-P5 with Respective Peptide Components
The next step of the project was to characterize the MBB P3-P5 with its respective
peptide constituents P3 and P5. Figure 4.3 compares MBB P3-P5 (black) to the individual
peptides that were used in the reaction. This chromatogram shows an earlier elution
volume of P3-P5, indicating the formation of a larger species. This supports the covalent
linkage of P3 (red) and P5 (blue) was successful. It is observed that the P3-P5 peak is
broadened and has a tailing shoulder which suggests that unreacted P3 is also present in
the sample. Moving forward, the P3-P5 clicked product will need to be purified via HPLC
to remove any unreacted P3. Overall, this data supports the successful synthesis of P3-P5
via CuAAC on resin with TBTA.
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Figure 4.3. SEC analysis of P3 (red), P5 (blue), and crosslinked MBB P3-P5 (black).

4.4 Characterization of Assembled Peptidic Molecular Building Blocks
The next step in the project was to characterize the self-assembly of MBB P3-P5
with the respective pairing partners P4 and P6. Based on the data shown, the P3-P5 clicked
product was a mixture of P3-P5 and unreacted P3. The product was extensively washed to
remove any trace of unreacted or excess P5 during the CuAAC reaction. The addition of
P6 to P3-P5 was expected to reduce the elution volume further, indicating that the
association of P5 and P6 occur, producing P3-P5|P6. Complex P3-P5|P6 was considered
the first-generation assembly of multiple MBBs. As seen in Figure 4.4, the excepted shift
to a smaller elution volume was observed, suggesting a larger molecular species was
formed. Furthermore, the chromatogram also shows separation from the unreacted P3 that
is present in the sample. This further suggests that P3-P5 was successfully synthesized and
the self-assembly of multiple MBBs occurred. This assembly occurred, as designed, while
in the presence of additional peptides that did not have intermolecular interactions.
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Figure 4.4. SEC analysis of MBB P3-P5 before association (red) and after association
(blue) with P6.
P4 was then added to the first-generation assembly P3-P5|P6. Similar to before, the
addition of another peptide association was expected to further reduce the elution volume
due to the second-generation assembly increasing in size/shape. As can be seen in Figure
4.5, an unexpected shift in the elution volume occurs when P4 was added to P3-P5|P6
(blue) to produce P4|P3-P5|P6 (red). Two shifts occurred with the addition of P4 to the
first-generation assembly P3-P5|P6. First, the elution volume of unreacted P3 was reduced
as it assembled with P4, as expected. However, an unexpected increase in the elution
volume for the second-generation assembly also occurred. Two conclusions could be
proposed from this data. As discussed earlier, SEC chromatography is size and shape
dependent. The elution volume of each MBB and the subsequent assemblies cannot be
based solely on their molecular weights during elution in size-exclusion chromatography.
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Figure 4.5. SEC analysis of MBB P3-P5 before association (red) and after association
(blue) with P6.
Even though each generational assembly increased in molecular weight, the overall shape
of the assembled structure can also change. First, each assembly has structural differences
in associated and unassociated peptides. The unassociated peptides were expected to
remain as random coils while the associated peptides were expected to form well defined
coiled-coil secondary structures. Therefore, it was proposed that two-thirds of P3-P5|P6
exhibited as an ordered structure (i.e. coiled coil) while one-third was disordered (i.e.
random coil). Using the same comparison to the second-generation assembly, P4|P3-P5|P6
was expected to be fully formed as a defined structure of coiled coils. It was proposed that
the structural ordering of the coiled coils caused the size of the quaternary structure to
condense into a smaller shape when compared to the disordered random coil. Therefore,
the first-generation assembly may have been larger in size/shape because it had more
disordered components than the second-generation assembly which was completely
ordered into coiled coils. These small differences in shape and size could explain the
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unexpected observed shift in the second-generation assembly because its global structure
may have become smaller. The smaller structure likely caused the assembly to take the
longer pathway through the SEC column which equated to a larger elution volume as
observed.
The second conclusion that could be derived from these results was that an
unwanted peptide association occurred, P5 caused an interference of the P3|P4 association,
a dynamic equilibrium occurred when multiple associations are present, or a combination
of these events occurred. To evaluate these unexpected interactions, two separate mixtures
were analyzed. First, Figure 4.6 shows the mixture of molar equivalents of individual
peptides P3, P5, and P6 (blue), and clearly shows that two species eluted. This data
suggests that the association of P5|P6 at the lower elution volume and P3 at the higher
elution volume are present. This indicates a strong association of peptides P5 and P6 in
the presence of P3. The data also suggests that P3 does not interfere with the association
of P5|P6. Next, Figure 4.6 also shows the mixture of molar equivalents of individual
peptides P3, P4, and P5 (red). This mixture was expected to show similar results as the P3,
P5, and P6 mixture, but an unexpected result was observed. The mixture of P3, P4, and P5
does not have two distinct peaks, which would be indicative of two unique species present.
Instead, one broad elongated peak was observed which suggests that P5 may cause one or
more dynamic interaction to occur. This data suggests three conclusions. First, P4 and P5
did not form an unwanted association of P4|P5. This was consistent with the design
parameters of the project and originally findings from Gradišar. However, P5 may interfere
with the association of P3|P4. Alone, P3 and P4 make a strong association as seen in Figure
4.1, but this association could be weakened by the presence of P5. This hypothesis would
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Figure 4.6. Comparative analysis of peptide mixture P3, P4, & P5 (red) with peptide
mixture P3, P5, & P6 (blue).
further explain the unexpected shift in elution volume for MBB P4|P3-P5|P6 as shown in
Figure 4.5. The mixture of P3, P4, and P5 showed a broad, symmetrical peak in the sizeexclusion chromatogram, which also suggests that a degree of dynamic equilibrium
occurred. These peptide interactions were modified from original work published by
Gradišar in 2011.62 The design of the peptides presented here focused on modifying the
surface residues (ie positions b, c, and f) because they do not contribute to the specificity
and stability of the orthogonal coiled-coil dimers. It was assumed that peptide association
was mainly based on the hydrophobic interactions of positions a and d and the electrostatic
interactions of positions e and g, and that these interactions were strong enough to
overcome any changes to the surface residues. However, more recent studies have shown
that modification of these surface residues does play a role in local helical propensity, and
in certain cases could destabilize interacting peptides.84
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In conclusion, data supports strong association of peptide partners when additional peptidic
interferences are absent, but association strength of P3|P4 is potentially weakened when P5
is present. Data also supports the successful synthesis of MBB P3-P5, and the selfassembly of P3-P5|P6. However, the association of P4|P3-P5|P6 is inconclusive due to the
assumed weakened association of P3|P4 in the presence of P5. Finally, SEC analysis is not
able to resolve and characterize mixtures of peptides and MBBs. Molecular and structural
dynamics of size and shape cause unpredictable shifts is elution volume.

4.5 Future Progress
4.5.1 Peptide Interference Analysis
Additional studies of the dynamic interactions of multiple peptides and/or MBB
need to be done. The association strength of P3|P4 should be studied further. Interference
studies could be done by systematically evaluating combination of individual peptides P3,
P4, and P5. This could be done by first analyzing the mixture of two peptides and then
adding the third peptide to see if an interference occurs. The following combinations are
suggested below in Table 4.1.

Initial
Mixture
P3 and P4
P3 and P5

Additional
Peptide
P5
P4

P4 and P5

P3

Table 4.1. Proposed peptide interference analysis
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A peptide pair association should occur in all three combinations. If SEC analysis shows
two distinct peaks, then the peptide combination is not interfered by the additional peptide
component. If the analysis instead shows one peak, then a correlation could be made that
the additional peptide component interferes with the associating peptide pair.

4.5.2 Additional Purification and Characterization.
The analytical limitations of SEC to identify the structural differences in peptides
and MBBs also needs to be addressed. Additional studies via mass spectrometry and
ultracentrifugation would help characterize unique species formed via peptide association.
Furthermore, long term analysis of these peptides and MBBs requires purified samples.
The MBBs synthesized in this work was completed with crude peptide products. Early
terminated peptides and unreacted peptide products would interfere with characterization
analysis. Purified peptides and MBBs would be needed to achieve a higher level of
confidence in the controlled self-assembly of the MBBs.
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APPENDIX A
USING UCSF CHIMERAX MOLECULAR VISUALIZATION PROGRAM

A.1 Introduction
UCSF ChimeraX (or simply ChimeraX) is a powerful program that can be used to
visual the tertiary structures of proteins and polynucleotide chains. ChimeraX is a nextgeneration molecular visualization program from the Resource for Biocomputing,
Visualization, and Informatics (RBVI) and can be downloaded free of charge for academic,
government, nonprofit, and personal use. ChimeraX was developed with support from
National Institutes of Health R01-GM129325 and the Office of Cyber Infrastructure and
Computational Biology, National Institute of Allergy and Infectious Diseases. ChimeraX
integrates with several crystallographic databases, most notably Protein Data Bank (PDB).
While ChimeraX is a very powerful molecular imaging software program, the
operating interface is not very intuitive or user friendly.

The following are basic

instructions for using ChimeraX. The instructions provided are focused on building and
modifying α-helical peptides from a sequence and uploading crystallographic images from
PDB. The following instructions are based on version 1.1 of ChimeraX.
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A.2 Building and Modifying Peptide Structures
A.2.1 Custom Building an α-Helical Peptide from an Amino Acid Sequence
The visual models of the tertiary structure of the peptide was initially constructed
from the amino acid sequence. Each α-helical peptide was added to the viewing window
through the Build Structure window. The Build Structure window was opened by
selecting Tools > Structural Editing > Build Structure. The Build Structure window
was then changed to peptide by selecting peptide from the add option on the left side of
the window. Using standard one letter amino acid abbreviations, the amino acid sequence
was typed in the Start Structure provided window. If this was a sequence for a new model
then new model was selected from the Put atoms in menu. If this was a sequence to add
to an existing model, then current model was selected from the Put atoms in menu. Once
all options were chosen, Apply was selected to open a new window where the Φ and Ψ
torsion angles were adjusted. Peptide models P1 through P8 were built using the defaulted
α-helix torsion angles and parameters. After the torsion angles were confirmed, OK was
selected to add the peptide to the main viewing window. Note that these parameters do not
account for any helical distortions that are commonly observed with coiled-coil
associations.

A.2.2 Uploading a Model from PDB
Each molecular model in the Protein Data Bank has a unique 4-character
identification code. PDB models were uploaded to the main viewing window through the
command line located at the bottom of the screen. “Open ####” was typed in the
Command line, where #### refers to the 4-character PDB identification code. This
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command uploaded all atomic coordination data related to the model. Therefore, additional
model components that are not seen when viewed from PDB were present in ChimeraX.
The model was then modified to visual show the final tertiary structure.

A.2.3 Modifying Atomic Structure of Existing Models
If needed, the atomic structure of the model was modified through the Build
Structure window. This was useful for building peptides with unnatural amino acids or
adjusting existing models form PDB. Each peptide in this project had one unnatural amino
acid that is not recognized by ChimeraX. Therefore, natural amino acid was used in place
of the unnatural residue during the building of the peptide sequence. To reduce the
modification steps and time, the natural residue that was selected for substitution was one
that most structurally matched the final modified residue. First, the unwanted atoms in the
sidechain residue was deleted. Next, the Build Structure window was changed to modify
structure from the drop-down menu at the top of the window. Then, atoms were added as
necessary by selecting the appropriate element, bond number, and geometry respectively.
Once the new parameters of the atom was set, the Apply button added the new atom to the
currently selected atom of the model.
At this time, version 1.1 did not allow for the addition of bonds between two
selected atoms. Therefore, physical closing of ring structures or covalently linking two
peptides together was unfeasible. Since the models used in this work were for visualization
purposes, these modification limitations were overcome by adding another atom that
matched the connecting atom and rotating the bond to overlay the two atoms.
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A.3 Selecting and Adjusting Visual Parameters
Different visualizations of the model were adjusted using the Molecule Display
menu tab. Most notably, the side chain atoms, peptide ribbons, and molecular surfaces
were be added, removed, or modified. Molecular bonding visuals and model coloring were
also adjusted through this tab. Selecting individual components of the model was done via
the Select tool found in the Right Mouse menu tab. Note that the right mouse button was
needed to be used for any option in this menu. This tab allowed for movement of entire
model(s) or specific components in a model.
Advanced selection tools were also found in the Select menu. Multiple atoms or
residues were selected in bulk using the different selection options available form this
menu. For example, entire chains, specific atoms, functional groups, residues, and/or
custom sequences were quickly selected based on the selection criteria chosen. This was
useful for selecting and modifying one or multiply components in very large, complex
models.
Custom coloring of model components was done through the Actions menu. First,
the component(s) of the model that was modified were selected. Then, color of the selected
component(s) was changed by the Actions > Color menu option. Additional visualizations
of the selected components were also changed from the Actions menu. Action > Cartoon
> Rounded Edges were selected for all peptide ribbons used in this project.
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APPENDIX B
METHOD DEVELOPMENT FOR THE PURIFICATION OF PEPTIDES

B.1 Semi-Preparative HPLC Method Development
Method development included semi-preparative purification of individual peptides.
It was determined that the crude synthesized peptides were of sufficient purity to begin
developing methods for the CuAAC clicked peptide pairs, and therefore purification of
peptides was stopped. However, the following method was developed and used to purify
the individual peptides.
Peptides were purified via reverse phase high-performance liquid chromatography
(RP-HPLC) using an Agilent 1200 Series HPLC. Peptide solutions (1-5 mg/mL in 0.1%
ammonium bicarbonate) were manually injected (1-5 mL) and separated with an Agilent
ZORBAX 300SB-C18 column (9.4 x 250 mm, 5 µm). Millipore H2O/TFA (99.9:0.1 vol%)
and acetonitrile/Millipore H2O/TFA (97.9:2.0:0.1 vol%) were used as mobile phase A and
B respectively. Eluted components were monitored by UV absorbance at 210 nm. The
concentration of B was increased linearly from 20 to 40% over 20 minutes (1% B per min)
with a total flow rate of 5 mL/min. At 40% B, the linear gradient was increased to 5% B
per minute until [B] reached 90%. Target peak fractions were collected manually for each
peptide respectively. Figures B.1–B.4 illustrate representative HPLC chromatograms of
crude peptides.
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While this method successfully purified the crude peptides, the semi-preparative
column had low loading capacity. The low column capacity produced ineffective yields
for this project and was deemed ineffective at this time. Method development of the
CuAAC reaction became the focus of this project.

Figure B.1. HPLC analysis of crude peptide P3 using semi-preparative column.

Figure B.2. HPLC analysis of crude peptide P4 using semi-preparative column.
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Figure B.3. HPLC analysis of crude peptide P5 using semi-preparative column.

Figure B.4. HPLC analysis of crude peptide P6 using semi-preparative column.
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B.2 His6-TEV Tag for Nickel Affinity Purification
Another method was developed to purify the individual peptides. Peptide P3 was
synthesized with an additional sequence that could be purified via nickel affinity
chromatography. After purification, the additional amino acid sequence was cleaved from
the peptide using a TEV protease.85 While this method was successful in purifying the
crude product, it was determined that this method was also inefficient. This method
utilized significantly more solvents and reagents, and increased the time needed to
synthesis one peptide. The added cost and time required to perform this method was not
offset with a significantly more purified product.
The N-terminus of peptide P3 was modified with the amino acid sequence
HHHHHHQNLYFQ. Nickel affinity chromatography was used to purify the peptide.
Only full length peptides that contained the histidines would bind to the column, allowing
for the all other components (i.e. anything without the His tag) to be eluted. A high salinity
elution solvent was then used to elute the histidine labeled peptide. A TEV protease was
then used to cleave the histidines from the peptide. TEV protease is a chymotrypsin-like
protease that offers a high sequence specificity for the controlled cleavage of fusion
proteins. The TEV protease used recognized the QNLYFQ/S sequence and cleaves the
sequence at the Q/S site. This left serine on the peptide as part of the SPED tetrapeptide
capping of P3 and removed the histidine purifying tag. Figures B.5–B.6 show HPLC
chromatograms of histidine labeled P3 before and after nickel affinity purification, but
before cleavage of the histine tag.
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Figure B.5. HPLC analysis of crude P3-HisTag at 210nm. Histidine/TEV amino acid
sequence added to end of the P3 sequence. Nickel affinity chromatography was used to
purify crude peptide followed by TEV protease to cleave the HisTag from the product.

Figure B.6. HPLC analysis of purified P3-HisTag at 210nm. Shown is the analysis of P3HisTag after purification via nickel affinity chromatography. HisTag has not been cleaved
from P3.
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APPENDIX C
DETERMINING EFFECTIVE LOADING OF PEPTIDE BOUND WANG RESIN

C.1 Description of Calculation Method
As discussed previously, one of the CuAAC reaction methods was done while P3
was still attached to the resin. Covalent linking of P3 on resin with P5 off resin was utilized
as a purification method. This method clicked P5 to P3 on resin, which then allowed any
excess P5 and CuAAC reagents to be easily removed via filtration. P5 needed to be added
in stoichiometrical equivalence to P3. However, the amount of P3 on resin was unknown.
The amount of P3 on resin was determined by the initial resin loading of tyrosine bound
Wang resin. Assuming a 100% coupling efficiency of all amino acids during synthesis,
the theoretical amount of P3 on resin was equal to the reaction scale of 0.2 mmol. The
mass of the resin with P3 was measured after sufficient drying of the resin. The new
effective loading of the resin with P3 was determined by dividing the theoretical moles of
P3 by the mass of the dried resin with P3. See sample calculation below.
1. Mass of resin with P3 (dried): 1.1774 g
2. Initial loading of Tyr-Wang resin: 0.56 mmol/g
3. Initial weight of Tyr-Wang resin: 0.357 g
0.56 𝑚𝑚𝑜𝑙 𝑇𝑦𝑟
𝑥 0.357 𝑔 𝑇𝑦𝑟-𝑤𝑎𝑛𝑔 𝑟𝑒𝑠𝑖𝑛
1 𝑔 𝑇𝑦𝑟-𝑤𝑎𝑛𝑔 𝑟𝑒𝑠𝑖𝑛
0.20 𝑚𝑚𝑜𝑙 𝑃3
1.1774 𝑔 𝑃3-𝑤𝑎𝑛𝑔 𝑟𝑒𝑠𝑖𝑛

0.20 𝑚𝑚𝑜𝑙 𝑇𝑦𝑟

0.20 𝑚𝑚𝑜𝑙 𝑃3

0.1699 𝑚𝑚𝑜𝑙/𝑔 𝑒𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒 𝑙𝑜𝑎𝑑𝑖𝑛𝑔
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APPENDIX D
HPLC CHROMATOGRAPHIC DATA

Figure D.1. HPLC analysis of crude peptide P1 at 210nm.

Figure D.2. HPLC analysis of crude peptide P2 at 210nm
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Figure D.3. HPLC analysis of crude peptide P3 at 210nm

Figure D.4. HPLC analysis of crude peptide P3 at 280nm
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Figure D.5. HPLC analysis of crude peptide P4 at 210nm

Figure D.6. HPLC analysis of crude peptide P5 at 210nm
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Figure D.7. HPLC analysis of crude peptide P5 at 280nm

Figure D.8. HPLC analysis of crude peptide P6 at 210nm
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Figure D.9. HPLC analysis of crude peptide P7 at 210nm

Figure D.10. HPLC analysis of crude peptide P8 at 210nm
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Figure D.11. HPLC analysis of blank. Ammonium bicarbonate (0.1% m/v) was used to
dissolve peptides.

Figure D.12. HPLC analysis of P3-P5 at 210nm. CuAAC reaction between P3 and P5
without an accelerating ligand.
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Figure D.13. HPLC analysis of P3-P5 at 280nm. CuAAC reaction between P3 and P5
without an accelerating ligand.

Figure D.14. HPLC analysis of P3-P5 at 210nm. CuAAC reaction between P3 and P5
utilizing TMPA as an accelerating ligand.
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Figure D.15. HPLC analysis of P3-P5 at 210nm. CuAAC reaction between P3 and P5
utilizing TBTA as an accelerating ligand.

Figure D.16. HPLC analysis of P3-P5 at 280nm. CuAAC reaction between P3 and P5
utilizing TBTA as an accelerating ligand.
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Figure D.17. HPLC stacked analysis of P3 (red), P5 (blue), and P3-P5 (black) at 280nm.
CuAAC reaction between P3 and P5 utilizing TBTA as an accelerating ligand. P5 has
been time adjusted due to changes in elution solvent.
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APPENDIX E
SEC CHROMATOGRAPHIC DATA

Figure E.1. SEC analysis of Bio-Rad gel filtration lyophilized mix of thyroglobulin (Mr
670,000), bovine γ-globulin (Mr 158,000), chicken ovalbumin (Mr 44,000), equine
myoglobin (Mr 17,000), and vit B12 (Mr 1,350), pI 4.5–6.9.
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Figure E.2. SEC analysis of peptide P3.

Figure E.3. SEC analysis of peptide P4.
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Figure E.4. SEC analysis of peptide P5.

Figure E.5. SEC analysis of peptide P6.
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Figure E.6. SEC analysis of the association of peptide pair P3|P4.

Figure E.7. SEC analysis of the association of peptide pair P5|P6.
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Figure E.8. Comparative analysis of peptides P3 (red), P4 (blue), and the associated
product of peptides P3|P4 (black). The shift in elution volume shows the association of the
individual peptides to form P3|P4 peptide pair.

Figure E.9. Comparative analysis of peptides P5 (red), P6 (blue), and the associated
product of peptides P5|P6 (black). The shift in elution volume shows the association of the
individual peptides to form P5|P6 peptide pair.

97

Figure E.10. SEC analysis of CuAAC reaction of P3 with P5.

Figure E.11. SEC analysis of CuAAC reaction of P3 with P5 using TMPA as an
accelerating ligand.
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Figure E.12. SEC analysis of CuAAC reaction of P3 with P5 using TBTA as an
accelerating ligand.

Figure E.13. Comparative analysis of peptides P3 (red), P5 (blue), and the CuAAC product
P3-P5 (black). The shift in elution volume suggests successful covalent bonding of P3 and
P5 to form the MBB P3-P5.
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Figure E.14. Comparative analysis of peptides P3 (red), P5 (blue), and the CuAAC product
P3-P5 using TMPA (black). The absence of a shift in the elution volume suggests TMPA
is not an effective accelerating ligand.

Figure E.15. Comparative analysis of peptides P3 (red), P5 (blue), and the CuAAC product
P3-P5 using TBTA (black). The shift in elution volume suggests successful covalent
bonding of P3 and P5 to form the MBB P3-P5.
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Figure E.16. Comparative analysis of peptide mixture P3, P4, & P5 (red) with peptide
mixture P3, P5, & P6 (blue).
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APPENDIX F
MASS SPECTROMETRY DATA

Figure F.1. Mass spectrum of P3 using MALDI.
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Figure F.2. Mass spectrum of P5 using MALDI.

Figure F.3. Mass spectrum of P6 using MALDI.
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Figure F.4. Mass spectrum of P7 using MALDI.

Figure F.5. Mass spectrum of P8 using MALDI.
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